Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish. The daily moving averages indicate a bullish stance. However, the KST is mildly bearish on both weekly and monthly time frames, and the Dow Theory shows a mildly bearish signal on the weekly but a mildly bullish signal on the monthly. The Bollinger Bands are mildly bullish for both weekly and monthly periods, and the OBV is bullish monthly but mildly bearish weekly.
In terms of performance, Neurocrine has underperformed the S&P 500 over the past week and month, with returns of -3.50% and 0.68% respectively, while the S&P 500 returned 1.09% and 4.15%. Over the longer term, the stock has outperformed the S&P 500 on a 1-year basis with a return of 22.48% compared to 17.82%. However, it has significantly lagged over the 3-year, 5-year, and 10-year periods. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and moving averages, tempered by mixed signals from KST and Dow Theory.